المؤلفون: Carles J; Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain; Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain; Universitat Autónoma de Barcelona, Barcelona, Spain. Electronic address: jcarles@vhio.net., Alonso-Gordoa T; Medical Oncology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain., Mellado B; Medical Oncology Department, Hospital Clínic Barcelona, Barcelona, Spain; Translational Genomics and Targeted Therapeutics in Solid Tumors Lab, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain., Méndez-Vidal MJ; Maimonides Institute for Biomedical Research of Córdoba (IMIBIC), Córdoba, Spain; Reina Sofía University Hospital (HURS), Córdoba, Spain., Vázquez S; Lucus Augusti University Hospital, Lugo, Spain., González-Del-Alba A; Puerta de Hierro-Majadahonda University Hospital, Madrid, Spain., Piulats JM; Catalan Institute of Oncology, Barcelona, Spain., Borrega P; San Pedro de Alcántara Hospital, Cáceres, Spain., Gallardo E; Parc Taulí University Hospital, Parc Taulí Institute of Research and Innovation I3PT, Barcelona, Spain., Morales-Barrera R; Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain; Universitat Autónoma de Barcelona, Barcelona, Spain., Paredes P; Medical Oncology Department, Hospital Clínic Barcelona, Barcelona, Spain; Translational Genomics and Targeted Therapeutics in Solid Tumors Lab, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain., Reig O; Medical Oncology Department, Hospital Clínic Barcelona, Barcelona, Spain; Translational Genomics and Targeted Therapeutics in Solid Tumors Lab, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain., Garcías de España C; Son Espases University Hospital, Mallorca, Spain., Collado R; Son Espases University Hospital, Mallorca, Spain., Bonfill T; Complejo Hospitalario de Caceres, Cáceres, Spain., Suárez C; Universitat Autónoma de Barcelona, Barcelona, Spain; Parc Taulí University Hospital, Parc Taulí Institute of Research and Innovation I3PT, Barcelona, Spain., Sampayo-Cordero M; Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain., Malfettone A; Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain., Garde J; Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain.

المصدر: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2022 Sep; Vol. 173, pp. 317-326. Date of Electronic Publication: 2022 Aug 16.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Bone Neoplasms*/secondary , Prostatic Neoplasms, Castration-Resistant*/pathology, Abiraterone Acetate/therapeutic use ; Androgen Antagonists/therapeutic use ; Benzamides ; Humans ; Male ; Nitriles/therapeutic use ; Phenylthiohydantoin ; Radium ; Receptors, Androgen